DARWIN BIOPROSPECTING EXCELLENCE SOCIEDAD LIMITADA

Their core work

Darwin Bioprospecting is a Spanish biotech SME specializing in microbial diversity — discovering, cataloging, and engineering microbial communities for industrial applications. They provide microbial enzymes and synthetic biology expertise to solve problems in plastic waste treatment and biogas production. Their core capability is turning natural microbial biodiversity into functional tools for circular economy applications, bridging the gap between environmental microbiology and industrial biotechnology.

What they specialise in

How they've shifted over time

Darwin started in 2018 with foundational work on synthetic biology standards and international coordination (BioRoboost), positioning themselves within the regulatory and standardisation landscape. By 2020-2021, they shifted decisively toward applied industrial biotechnology — enzymatic plastic recycling (ENZYCLE) and biogas microbiome engineering (MICRO4BIOGAS). The trajectory is clear: from standards-setting to hands-on microbial solutions for circular economy challenges.

Darwin is moving from foundational standards work toward applied microbial solutions for waste valorisation and bioenergy, making them increasingly relevant for circular bioeconomy consortia.

How they like to work

Darwin operates exclusively as a participant, never as coordinator, which is typical for a specialist SME contributing deep technical expertise to larger consortia. With 52 unique partners across 18 countries from just 3 projects, they join broad European consortia rather than small focused teams. This suggests they are comfortable integrating into complex multi-partner projects and delivering specialized microbial/enzymatic capabilities within a larger research effort.

Despite only three projects, Darwin has built a surprisingly wide network of 52 partners across 18 countries, reflecting their participation in large pan-European consortia. Their reach extends well beyond the Iberian Peninsula into a genuinely European collaborative footprint.

What sets them apart

Darwin sits at a rare intersection: they combine microbial bioprospecting (finding useful organisms in nature) with synthetic biology (engineering those organisms for purpose). For consortium builders, this means a single partner that can both discover candidate microbes and help engineer them for industrial-scale plastic degradation or biogas production. As a Valencia-based SME with hands-on lab capabilities, they offer agility and specialized know-how that larger research institutes often cannot match.

Highlights from their portfolio

• MICRO4BIOGAS
  Their largest project (EUR 577,440) combining microbiome science with synthetic biology for sustainable biogas — signals their most invested research direction.
• ENZYCLE
  Tackles the hard problem of non-recycled plastics (multi-layer, polyolefins) with microbial enzymes — a high-demand industrial application with strong commercial potential.